carbostyril has been researched along with Disease, Pulmonary in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.26) | 18.7374 |
1990's | 3 (15.79) | 18.2507 |
2000's | 4 (21.05) | 29.6817 |
2010's | 7 (36.84) | 24.3611 |
2020's | 4 (21.05) | 2.80 |
Authors | Studies |
---|---|
Mulrennan, S; Popowicz, N; Vekaria, S; White, SW | 1 |
Biglia, C; Calderazzo, MA; Caloiero, M; Cresta, F; De Venuto, D; Francalanci, M; Leonetti, G; Majo, F; Messore, B; Pisi, G; Pizzamiglio, G; Salvatore, D; Taccetti, G; Terlizzi, V | 1 |
Burgel, PR; Da Silva, J; Martin, C; Paillasseur, JL | 1 |
Harrison, J; Kuek, SL; Ranganathan, SC; Robinson, PJ; Shanthikumar, S | 1 |
Chang, LW; Chang, YT; Cheng, SL; Chuang, YC; Hsu, MC; Perng, WC; Tsao, SM; Wu, RG | 1 |
Chan, HK; Cipolla, D | 1 |
Barry, PJ; Bell, NJ; Bicknell, S; Daniels, T; Felton, I; Gunaratnam, C; Horsley, AR; Jones, AM; Nair, A; Plant, BJ; Shafi, NT; Shelmerdine, S; Simmonds, NJ | 1 |
Gillissen, A; Häussermann, A | 1 |
Ackland, ML; Danscher, G; Grosser, D; Knight, D; Lang, C; Michalczyk, A; Murgia, C; Perozzi, G; Roscioli, E; Ruffin, RE; Stoltenberg, M; Truong-Tran, AQ; Zalewski, P | 1 |
Backer, K; Byan-Parker, S; Courville, C; Dransfield, MT; Grizzle, W; Levin, E; Li, Y; Mazur, M; Raju, SV; Rowe, SM; Shastry, S; Sloane, PA; Sorscher, EJ; Tang, LP; Wilhelm, A | 1 |
Polenakovik, HM; Sanville, B | 1 |
Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Miyazaki, Y; Murata, I; Tashiro, T; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
Fukuda, Y; Higashiyama, Y; Hirakata, Y; Kohno, S; Miyazaki, Y; Mizuta, Y; Ohno, H; Tashiro, T; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
Kobashi, Y; Miyashita, N; Niki, Y; Oka, M; Yoshida, K | 1 |
Hodson, ME | 1 |
Gunnarsson, A; Pedersen Mörner, A; Segall, T; Wallgren, P | 1 |
Dobos-Kovács, M; Fodor, L; Makrai, L; Pelle, G | 1 |
Azoulay-Dupuis, E; Bergogne-Bérézin, E; Pocidalo, JJ; Vallée, E | 1 |
Brostoff, J; Flint, KC; Hudspith, BN; Johnson, NM; Lau, HY; Leung, KB; Liu, WL; Pearce, FL | 1 |
2 review(s) available for carbostyril and Disease, Pulmonary
Article | Year |
---|---|
Inhaled antibiotics to treat lung infection.
Topics: Administration, Inhalation; Aerosols; Aminoglycosides; Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Cystic Fibrosis; Dry Powder Inhalers; Humans; Lung Diseases; Monobactams; Nebulizers and Vaporizers; Patents as Topic; Quinolones; Respiratory Tract Infections | 2013 |
[Diseases of the lung and air passages 2010].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aminopyridines; Asthma; Benzamides; Cyclopropanes; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Indans; Lung Diseases; Lung Neoplasms; Neoplasm Staging; Phosphodiesterase 4 Inhibitors; Pneumonia, Bacterial; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinolones | 2010 |
2 trial(s) available for carbostyril and Disease, Pulmonary
Article | Year |
---|---|
Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Community-Acquired Infections; Double-Blind Method; Drug Combinations; Female; Fluoroquinolones; Humans; Levofloxacin; Lung Diseases; Male; Middle Aged; Pneumonia; Quinolones; Safety; South Africa; Taiwan; Treatment Outcome; Young Adult | 2019 |
Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones; Radiography; Treatment Outcome | 2006 |
15 other study(ies) available for carbostyril and Disease, Pulmonary
Article | Year |
---|---|
To be or not to be on CFTR modulators during pregnancy: Risks to be considered.
Topics: Adult; Aminophenols; Bronchiectasis; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Delivery, Obstetric; Drug Dosage Calculations; Exocrine Pancreatic Insufficiency; Female; Gestational Age; Humans; Infant, Newborn; Lung Diseases; Monitoring, Physiologic; Mutation; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pseudomonas; Quinolones | 2020 |
Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function.
Topics: Adult; Aminophenols; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Mutation; Quinolones; Respiratory Function Tests; Retrospective Studies; Treatment Outcome; Young Adult | 2020 |
Reply to Kuek
Topics: Aminophenols; Benzodioxoles; Humans; Indoles; Lung Diseases; Pyrazoles; Pyridines; Pyrrolidines; Quinolones | 2021 |
Optimism with Caution: Elexacaftor-Tezacaftor-Ivacaftor in Patients with Advanced Pulmonary Disease.
Topics: Aminophenols; Benzodioxoles; Humans; Indoles; Lung Diseases; Pyrazoles; Pyridines; Pyrrolidines; Quinolones | 2021 |
Effects of ivacaftor in patients with cystic fibrosis who carry the G551D mutation and have severe lung disease.
Topics: Administration, Oral; Adult; Aminophenols; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA; DNA Mutational Analysis; Female; Follow-Up Studies; Forced Expiratory Volume; Genotype; Humans; Lung Diseases; Male; Mutation; Quinolones; Retrospective Studies; Severity of Illness Index; Young Adult | 2014 |
Apical localization of zinc transporter ZnT4 in human airway epithelial cells and its loss in a murine model of allergic airway inflammation.
Topics: Animals; Bronchi; Carrier Proteins; Cation Transport Proteins; Diet; Disease Models, Animal; Epithelial Cells; Fluorescent Dyes; Humans; Lung Diseases; Membrane Transport Proteins; Mice; Microscopy, Electron; Nasal Cavity; Quinolones; Rats; Reverse Transcriptase Polymerase Chain Reaction; Secretory Vesicles; Tosyl Compounds; Zinc | 2011 |
A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease.
Topics: Adult; Aged; Aged, 80 and over; Aminophenols; Cystic Fibrosis Transmembrane Conductance Regulator; Demography; Epithelial Cells; Female; Humans; Ion Transport; Lung Diseases; Male; Membrane Potentials; Middle Aged; Mucus; Quinolones; Smoking | 2012 |
The use of ivacaftor in an adult with severe lung disease due to cystic fibrosis (ΔF508/G551D).
Topics: Adult; Aminophenols; Cystic Fibrosis; Forced Expiratory Volume; Humans; Lung Diseases; Male; Quinolones; Severity of Illness Index | 2013 |
Effects of DQ-113, a new quinolone, against methicillin- and vancomycin-resistant Staphylococcus aureus-caused hematogenous pulmonary infections in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Blood-Borne Pathogens; Injections, Intraperitoneal; Lung; Lung Diseases; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Vancomycin Resistance | 2003 |
In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Lung Diseases; Mice; Mice, Inbred ICR; Pneumococcal Infections; Pyrrolidines; Quinolones; Streptococcus pneumoniae | 2006 |
Maintenance treatment with antibiotics in cystic fibrosis patients. Sense or nonsense?
Topics: Aerosols; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cystic Fibrosis; Humans; Infant; Lung Diseases; Quinolones | 1995 |
Experimental infections with Actinobacillus pleuropneumoniae in pigs--I. Comparison of five different parenteral antibiotic treatments.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Body Weight; Cephalosporins; Diterpenes; Enrofloxacin; Fluoroquinolones; Lung; Lung Diseases; Penicillins; Quinolones; Swine; Swine Diseases; Weight Gain | 1999 |
Actinomycosis of dogs caused by Actinomyces hordeovulneris.
Topics: Actinomyces; Actinomycosis; Amoxicillin; Animals; Anti-Infective Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Empyema, Pleural; Enrofloxacin; Fatal Outcome; Fluoroquinolones; Lung Diseases; Male; Microbial Sensitivity Tests; Pericarditis; Pericardium; Pleura; Pleurisy; Quinolones; Sulfamethoxazole; Trimethoprim | 2000 |
Pharmacokinetics of four fluoroquinolones in an animal model of infected lung.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Lung Diseases; Mice; Mice, Inbred Strains; Ofloxacin; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 1991 |
Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells.
Topics: Asthma; Bronchoalveolar Lavage Fluid; Cromolyn Sodium; Depression, Chemical; Dose-Response Relationship, Drug; Histamine Release; Humans; Lung; Lung Diseases; Mast Cells; Nedocromil; Quinolones; Sarcoidosis; Tachyphylaxis | 1988 |